Ghrelin Resistance Occurs in Severe Heart Failure and Resolves After Heart Transplantation
Authors:
Open Access
- 24 July 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 11 (8) , 789-794
Abstract
Aims: Severe heart failure (HF) is often associated with cachexia that reverses post-heart transplantation (HTx) with frequent development of obesity. Ghrelin is a novel appetite-stimulating hormone. The aim was to determine the role of ghrelin in regulating appetite, food intake, and body composition in HF and post-HTx. Methods and results: We measured serial ghrelin, hunger sensation, caloric intake, and body composition in 12 HF patients awaiting HTx, 12 patients 12.7 ± 8.6 months post-HTx, and 7 controls. Seven of 12 HF patients were followed for longitudinal analysis post-HTx. Body mass index was 23.1 ± 3.1 in HF and 31.5 ± 5.5 post-HTx (P < 0.001). Heart transplantation patients had gained 18.0 ± 7.7 kg since HTx. Ghrelin area under the curve between controlled meals (control: 186 ± 39; HF: 264 ± 71; HTx: 194 ± 47 ng min/mL, P < 0.007) was higher in HF, but test meal caloric intake (control: 1185 ± 650; HF: 391 ± 103; HTx: 831 ± 309 kcal, P < 0.008) was lower in HF. The longitudinal analysis confirmed these findings. Conclusion: Heart failure may be associated with resistance to the appetite-stimulating effects of ghrelin, which may contribute to cachexia. Heart transplantation may be associated with resolution of ghrelin resistance, which may contribute to weight gain. These findings are preliminary and should be confirmed in larger trials.Keywords
This publication has 20 references indexed in Scilit:
- Growth Hormone Resistance in Severe Heart Failure Resolves After Cardiac TransplantationEuropean Journal of Heart Failure, 2009
- Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programmeEuropean Heart Journal, 2008
- One ancestor, several peptidesMolecular and Cellular Endocrinology, 2006
- Ghrelin, a Novel Growth Hormonereleasing Peptide, in the Treatment of Cardiopulmonaryassociated CachexiaInternal Medicine, 2006
- Excessive Weight Gain in Cardiac Transplant RecipientsThe Journal of Heart and Lung Transplantation, 2006
- Effects of Ghrelin Administration on Left Ventricular Function, Exercise Capacity, and Muscle Wasting in Patients With Chronic Heart FailureCirculation, 2004
- Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humansClinical Science, 2003
- Elevated Circulating Level of Ghrelin in Cachexia Associated With Chronic Heart FailureCirculation, 2001
- Wasting as independent risk factor for mortality in chronic heart failureThe Lancet, 1997
- Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1989